Hug C, McGraw CA, Bates SR, et al. Reduction of serum carnitine concentrations during anticonvulsant therapy with phenobarbital, valproic acid, phenytoin, and carbamazepine in children.
J Pediatr.
1991;119:799-802.
Chung S, Choi J, Hyun T, et al. Alterations in the carnitine metabolism in epileptic children treated with valproic acid.
J Korean Med Sci.
1997;12:553-558.
Melegh B, Trombitas K. Valproate treatment induces lipid globule accumulation with ultrastructural abnormalities of mitochondria in skeletal muscle.
Neuropediatrics.
1997;28:257-261.
Zelnik N, Fridkis I, Gruener N. Reduced carnitine and antiepileptic drugs: cause relationship or co-existence?
Acta Paediatr.
1995;84:93-95.
Coulter DL. Carnitine deficiency in epilepsy: risk factors and treatment.
J Child Neurol.
1995;10(suppl 2):S32-S39.
Melegh B, Pap M, Morava E, et al. Carnitine-dependent changes of metabolic fuel consumption during long-term treatment with valproic acid.
J Pediatr.
1994;125:317-321.
De Vivo DC, Bohan TP, Coulter DL, et al. L-carnitine supplementation in childhood epilepsy: current perspectives.
Epilepsia.
1998;13:1216-1225.
Matsuda I, Ohtani Y. Carnitine status in Reye and Reye-like syndromes.
Pediatr Neurol.
1986;2:90-94.
Camina MF, Rozas I, Gomez M, et al. Short-term effects of administration of anticonvulsant drugs on free carnitine and acylcarnitine in mouse serum and tissues.
Br J Pharmacol.
1991;103:1179-1183.
Rodriguez-Segade S, de la Pena CA, Tutor JC, et al. Carnitine deficiency associated with anticonvulsant therapy.
Clin Chim Acta.
1989;181:175-181.
Ater SB. A developmental center population treated with VPA and L-carnitine. In: Update 1993: inborn errors of metabolism in the patient with epilepsy. Sigma-Tau Pharmaceuticals; 1993.
Cacciatore L, Cerio R, Ciarimboli M, et al. The therapeutic effect of L-carnitine in patients with exercise-induced stable angina: a controlled study.
Drugs Exp Clin Res.
1991;17:225-235.
Bartels GL, Remme WJ, Pillay M, et al. Effects of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris.
Am J Cardiol.
1994;74:125-130.
Bartels GL, Remme WJ, den Hartog FR, et al. Additional anti-ischemic effects of long-term L-propionylcarnitine in anginal patients treated with conventional antianginal therapy.
Cardiovasc Drugs Ther.
1995;9:749-753.
Bartels GL, Remme WJ, Holwerda KJ, et al. Anti-ischaemic efficacy of L-propionyl-carnitine—a promising novel metabolic approach to ischaemia?
Eur Heart J.
1996;17:414-420.
Cherchi A, Lai C, Angelino F, et al. Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo controlled crossover study.
Int J Clin Pharmacol Ther Toxicol.
1985;23:569-572.
Lagioia R, Scrutinio D, Mangini SG, et al. Propionyl-L-carnitine: a new compound in the metabolic approach to the treatment of effort angina.
Int J Cardiol.
1992;34:167-172.
Davini P, Bigalli A, Lamanna F, et al. Controlled study on L-carnitine therapeutic efficacy in post-infarction.
Drugs Exp Clin Res.
1992;18:355-365.
Iliceto S, Scrutinio D, Bruzzi P, et al. Effect of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial.
J Am Coll Cardiol.
1995;26:380-387.
Brevetti G, Perna S, Sabba C, et al. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study.
J Am Coll Cardiol.
1995;26:1411-1416.
Bolognesi M, Amodio P, Merkel C, et al. Effect of 8-day therapy with propionyl-L-carnitine on muscular and subcutaneous blood flow of the lower limbs in patients with peripheral arterial disease.
Clin Physiol.
1995;15:417-423.
Brevetti G, Perna S, Sabba C, et al. Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: an acute, intravenous, double-blind, cross-over study.
Eur Heart J.
1992;13:251-255.
Greco AV, Mingrone G, Bianchi M, et al. Effect of propionyl-L-carnitine in the treatment of diabetic angiopathy: Controlled double blind trial versus placebo.
Drugs Exp Clin Res.
1992;18:69-80.
Brevetti G, Chiariello M, Ferulano G, et al. Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study.
Circulation.
1988;77:767-773.
Deckert J. Propionyl-L-carnitine for intermittent claudication.
J Fam Pract.
1997;44:533-534.
Sabba C, Berardi E, Antonica G, et al. Comparison between the effect of L-propionylcarnitine, L-acetylcarnitine and nitroglycerin in chronic peripheral arterial disease: a haemodynamic double blind echo-Doppler study.
Eur Heart J.
1994;15:1348-1352.
Pepine CJ. The therapeutic potential of carnitine in cardiovascular disorders.
Clin Ther.
1991;13:2-21.
Brevetti G, Attisano T, Perna S, et al. Effect of L-carnitine on the reactive hyperemia in patients affected by peripheral vascular disease: a double-blind, crossover study.
Angiology.
1989;40:857-862.
Brevetti G, Diehm C, Lambert D. European multicenter study on propionyl-L-carnitine in intermittent claudication.
J Am Coll Cardiol.
1999;34:1618-1624.
Hiatt WR, Regensteiner JG, Creager MA, et al. Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication.
Am J Med.
2001;110:616-622.
Caponnetto S, Canale C, Masperone MA, et al. Efficacy of L-propionylcarnitine treatment in patients with left ventricular dysfunction.
Eur Heart J.
1994;15:1267-1273.
Mancini M, Rengo F, Lingetti M, et al. Controlled study on the therapeutic efficacy of propionyl-L-carnitine in patients with congestive heart failure.
Arzneimittelforschung.
1992;42:1101-1104.
Pucciarelli G, Mastursi M, Latte S, et al. The clinical and hemodynamic effects of propionyl-L-carnitine in the treatment of congestive heart failure [in Italian; English abstract].
Clin Ter.
1992;141:379-384.
Singh RB, Niaz MA, Agarwal P, et al. A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction.
Postgrad Med J.
1996;72:45-50.
Winter S, Jue K, Prochazka J, et al. The role of L-carnitine in pediatric cardiomyopathy.
J Child Neurol.
1995;10(suppl 2):S45-S51.
Iyer R, Gupta A, Khan A, et al. Does left ventricular function improve with L-carnitine after acute myocardial infarction?
J Postgrad Med.
1999;45:38-41.
Dal Negro R, Pomari G, Zoccatelli O, et al. L-carnitine and rehabilitative respiratory physiokinesitherapy: metabolic and ventilatory response in chronic respiratory insufficiency.
Int J Clin Pharmacol.
1986;24:453-456.
Dal Negro R, Turco P, Pomari C, et al. Effects of L-carnitine on physical performance in chronic respiratory insufficiency.
Int J Clin Pharmacol.
1988;26:269-272.
Dal Negro R, Zoccatelli D, Pomari C, et al. L-carnitine and physiokinesiotherapy in chronic respiratory insufficiency. Preliminary results.
Clin Trials J.
1985;22:353-360.
Passeri M, Cucinotta D, Bonati PA, et al. Acetyl-L-carnitine in the treatment of mildly demented elderly patients.
Int J Clin Pharmacol Res.
1990;10:75-79.
Calvani M, Carta A, Caruso G, et al. Action of acetyl-L-carnitine in neurodegeneration and Alzheimer's disease.
Ann N Y Acad Sci.
1992;663:483-486.
Sano M, Bell K, Cote L, et al. Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease.
Arch Neurol.
1992;49:1137-1141.
Spagnoli A, Lucca U, Menasce G, et al. Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
Neurology.
1991;41:1726-1732.
Campi N, Todeschini GP, Scarzella L. Selegiline versus L-acetylcarnitine in the treatment of Alzheimer-type dementia.
Clin Ther.
1990;12:306-314.
Vecchi GP, Chiari G, Cipolli C, et al. Acetyl-l-carnitine treatment of mental impairment in the elderly: evidence from a multicenter study.
Arch Gerontol Geriatr.
1991;(suppl 2):159-168.
Bonavita E. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain.
Int J Clin Pharmacol Ther Toxicol.
1986;24:511-516.
Thal LJ, Carta A, Clarke WR, et al. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease.
Neurology.
1996;47:705-711.
Thal LJ, Calvani M, Amato A, et al. A 1-year controlled trial of acetyl-l-carnitine in early-onset AD.
Neurology.
2000;55:805-810.
Bella R, Biondi R, Raffaele R, et al. Effect of acetyl-L-carnitine on geriatric patients suffering from dysthymic disorders.
Int J Clin Pharmacol Res.
1990;10:355-360.
Garzya G, Corallo D, Fiore A, et al. Evaluation of the effects of L-acetylcarnitine on senile patients suffering from depression.
Drugs Exp Clin Res.
1990;16:101-106.
Torrioli MG, Vernacotola S, Mariotti P, et al. Double-blind, placebo-controlled study of L-acetylcarnitine for the treatment of hyperactive behavior in fragile X syndrome.
Am J Med Genet.
1999;87:366-368.
Mingrone G, Greco AV, Capristo E, et al. L-carnitine improves glucose disposal in type 2 diabetic patients.
J Am Coll Nutr.
1999;18:77-82.
Turpeinen AK, Kuikka JT, Vanninen E, et al. Long-term effect of acetyl-L-carnitine on myocardial 123I-MIBG uptake in patients with diabetes.
Clin Auton Res.
2000;10:13-16.
Cavallini G, Biagiotti G, Koverech A, et al. Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease.
BJU Int.
2002;89:895-900.
Sorbi S, Forleo P, Fani C, et al. Double-blind, crossover, placebo-controlled clinical trial with L-acetylcarnitine in patients with degenerative cerebellar ataxia.
Clin Neuropharmacol.
2000;23:114-118.
Plioplys AV, Plioplys S. Amantadine and L-carnitine treatment of chronic fatigue syndrome.
Neuropsychobiology.
1997;35:16-23.
Benvenga S, Ruggeri RM, Russo A, et al. Usefulness of l-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial.
J Clin Endocrinol Metab.
2001;86:3579-3594.
Loumbakis P, Anezinis P, Evangeliou A, et al. Effect of L-carnitine in patients with asthenospermia [abstract].
Eur Urol.
1996;30(suppl 2):255.
Muller-Tyl E, Lohninger A, Fischl F, et al. The effect of carnitine on sperm count and sperm motility [translated from German].
Fertilitat.
1988;4:1-4.
Micic S, Lalic N, Nale DJ, et al. Effects of L-carnitine on sperm motility and number in infertile men [abstract].
Fertil Steril.
1998;70(3 suppl 1):S12.
Vicari E. Effectiveness of a short-term anti-oxidative high-dose therapy on IVF program outcome in infertile male patients with previous excessive sperm. In: International Meeting on Infertility and Assisted Reproductive Technology; Porto Cervo, Italy; June 11-14, 1997.
Vicari E, Cerri L, Cataldo T, et al. Effectiveness of single and combined antioxidant therapy in patients with astheno-necrozoospermia from non-bacterial epididymitis: effects after acetyl-carnitine or carnitine-acetyl-carnitine. Presented at: 12th National Conference, Italian Andrology Association; June 9-12, 1999; Copanello, Italy.
Campaniello E, Petrarolo N, Meriggiola MC, et al. Carnitine administration in asthenospermia. Presented at: 4th International Congress of Andrology; May 14-18, 1989; Florence, Italy.
Costa M, Canale D, Filicori M, et al. L-carnitine in idiopathic asthenozoospermia: a multicenter study.
Andrologia.
1994;26:155-159.
Vitali G, Parente R, Melotti C. Carnitine supplementation in human idiopathic asthenospermia: clinical results.
Drugs Exp Clin Res.
1995;21:157-159.
Moncada ML, Vicari E, Cimino C, et al. Effect of acetylcarnitine treatment in oligoasthenospermic patients.
Acta Eur Fertil.
1992;23:221-224.
Semino-Mora MC, Leon-Monzon ME, Dalakas MC. Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: L-carnitine prevents the myotoxicity of AZT in vitro.
Lab Invest.
1994;71:102-112.
Dalakas MC, Leon-Monzon ME, Bernardini I, et al. Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage.
Ann Neurol.
1994;35:482-487.
Heinonen OJ. Carnitine and physical exercise.
Sports Med.
1996;22:109-132.
Montgomery SA, Thal LJ, Amrein R. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease.
Int Clin Psychopharmacol.
2003;18:61-71
Lenzi A, Lombardo F, Sgro P, et al. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial.
Fertil Steril.
2003;79:292-300.
Montgomery SA, Thal LJ, Amrein R. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease.
Int Clin Psychopharmacol.
2003;18:61-71.
Van Oudheusden L, Scholte H. Efficacy of carnitine in the treatment of children with attention-deficit hyperactivity disorder.
Prostaglandins Leukot Essent Fatty Acids.
2002;67:33.
Biagiotti G, Cavallini G. Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report.
BJU Int.
2001;88:63-67.
Benvenga S, Lakshmanan M, Trimarchi F. Carnitine is a naturally occurring inhibitor of thyroid hormone nuclear uptake.
Thyroid.
2000;10:1043-1050.
Rai G, Wright G, Scott L, et al. Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia.
Curr Med Res Opin.
1990;11:638-647.
Salvioli G, Neri M. L-acetylcarnitine treatment of mental decline in the elderly.
Drugs Exp Clin Res.
1994;20:169-176.
Cipolli C, Chiari G. Effects of L-acetylcarnitine on mental deterioration in the aged: initial results [in Italian; English abstract].
Clin Ter.
1990;132:479-510.
Loster H, Miehe K, Punzel M, et al. Prolonged oral L-carnitine substitution increases bicycle ergometer performance in patients with severe, ischemically induced cardiac insufficiency.
Cardiovasc Drugs Ther.
1999;13:537-546.
Lenzi A, Sgro P, Salacone P, et al. A placebo-controlled double-blind randomized trial of the use of combined L-carnitine and L-acetyl-carnitine treatment in men with asthenozoospermia.
Fertil Steril.
2004;81:1578-1584.
Cavallini G, Caracciolo S, Vitali G, et al. Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging.
Urology.
2004;63:641-646.
Gentile V, Vicini P, Prigiotti G, et al. Preliminary observations on the use of propionyl-L-carnitine in combination with sildenafil in patients with erectile dysfunction and diabetes.
Curr Med Res Opin.
2004;20:1377-1384.
Sima AA, Calvani M, Mehra M, et al. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials.
Diabetes Care.
2004;28:89-94.
Pistone G, Marino A, Leotta C, et al. Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigue.
Drugs Aging.
2003;20:761-767.
Rahbar AR, Shakerhosseini R, Saadat N, et al. Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus.
Eur J Clin Nutr.
2005 Mar 2. [Epub ahead of print]
Cavallini G, Ferraretti AP, Gianaroli L, et al. Cinnoxicam and L-carnitine/acetyl-L-carnitine treatment for idiopathic and varicocele-associated oligoasthenospermia.
J Androl.
2004;25:761-770; discussion 771-772.
Pistone G, Marino A, Leotta C, et al. Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigue.
Drugs Aging.
2003;20:761-767.
Villani RG, Gannon J, Self M, et al. L-Carnitine supplementation combined with aerobic training does not promote weight loss in moderately obese women.
Int J Sport Nutr Exerc Metab.
2000;10:199-207.
Tarantini G, Scrutinio D, Bruzzi P, et al. Metabolic Treatment with L-Carnitine in Acute Anterior ST Segment Elevation Myocardial Infarction. A Randomized Controlled Trial.
Cardiology.
2006 May 9. [Epub ahead of print]
Garolla A, Maiorino M, Roverato A, et al. Oral carnitine supplementation increases sperm motility in asthenozoospermic men with normal sperm phospholipid hydroperoxide glutathione peroxidase levels.
Fertil Steril.
2005;83:355-361.
Balercia G, Regoli F, Armeni T, et al. Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia.
Fertil Steril.
2005;84:662-671.
Sigman M, Glass S, Campagnone J, et al. Carnitine for the treatment of idiopathic asthenospermia: a randomized, double-blind, placebo-controlled trial.
Fertil Steril.
2006 Apr 4. [Epub ahead of print]
Cavallini G, Modenini F, Vitali G, et al. Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy.
Urology.
2005;66:1080-1085.
Zanardi R, Smeraldi E. A double-blind, randomised, controlled clinical trial of acetyl-l-carnitine vs. amisulpride in the treatment of dysthymia.
Eur Neuropsychopharmacol.
2005 Nov 25. [Epub ahead of print]
Maestri A, De Pasquale Ceratti A, Cundari S, et al. A pilot study on the effect of acetyl-L-carnitine in paclitaxel- and cisplatin-induced peripheral neuropathy.
Tumori.
2005;91:135-138.
Malaguarnera M, Pistone G, Elvira R, et al. Effects of L-carnitine in patients with hepatic encephalopathy.
World J Gastroenterol.
2006;11:7197-202.
Stuessi C, Hofer P, Meier C, et al. L: -Carnitine and the recovery from exhaustive endurance exercise: a randomised, double-blind, placebo-controlled trial.
Eur J Appl Physiol.
2005 Sep 29. [Epub ahead of print]
Tarantini G, Scrutinio D, Bruzzi P, et al. Metabolic Treatment with L-Carnitine in Acute Anterior ST Segment Elevation Myocardial Infarction. A Randomized Controlled Trial.
Cardiology.
2006 May 9. [Epub ahead of print]
Cavallini G, Modenini F, Vitali G, et al. Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy.
Urology.
2005;66:1080-1085.
Garolla A, Maiorino M, Roverato A, et al. Oral carnitine supplementation increases sperm motility in asthenozoospermic men with normal sperm phospholipid hydroperoxide glutathione peroxidase levels.
Fertil Steril.
2005;83:355-361.
Balercia G, Regoli F, Armeni T, et al. Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia.
Fertil Steril.
2005;84:662-671.
Zanardi R, Smeraldi E. A double-blind, randomised, controlled clinical trial of acetyl-l-carnitine vs. amisulpride in the treatment of dysthymia.
Eur Neuropsychopharmacol.
2005 Nov 25. [Epub ahead of print]
Zhou X, Liu F, Zhai S. Effect of L-carnitine and/or L-acetyl-carnitine in nutrition treatment for male infertility: a systematic review.
Asia Pac J Clin Nutr.
2007;16(suppl):383-390.
Strauss M, Porras N. Differential expression of HSP70 and ultrastructure of heart and liver tissues of rats treated with adriamycin: protective role of L-carnitine.
Invest Clin.
2007;48:33-43.
Youle M, Osio M. A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl l-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection.
HIV Med.
2007;8:241-250.
Rossini M, Di Munno O, Valentini G, et al. Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients.
Clin Exp Rheumatol.
2007;25:182-188.
Ciacci C, Peluso G, Iannoni E, et al. L-Carnitine in the treatment of fatigue in adult celiac disease patients A pilot study.
Dig Liver Dis.
2007 Aug 9. [Epub ahead of print]
Malaguarnera M, Cammalleri L, Gargante MP, et al. L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial.
Am J Clin Nutr.
2007;86:1738-44.
Mitwalli AH, Al-Wakeel JS, Alam A, et al. L-carnitine supplementation in hemodialysis patients.
Saudi J Kidney Dis Transpl.
2005;16:17-22.
Smith WA, Fry AC, Tschume LC, et al. Effect of glycine propionyl-L-carnitine on aerobic and anaerobic exercise performance.
Int J Sport Nutr Exerc Metab.
2008;18:19-36.
Arnold LE, Amato A, Bozzolo H, et al. Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial.
J Child Adolesc Psychopharmacol.
2007;17:791-802.
Malaguarnera M, Gargante MP, Cristaldi E, et al. Acetyl-L:-carnitine treatment in minimal hepatic encephalopathy.
Dig Dis Sci.
2008 Mar 21.
Malaguarnera M, Gargante MP, Russo C, et al. L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis—a randomized and controlled clinical trial.
Am J Gastroenterol.
2010;105(6):1338-1345.
Dietary supplement fact sheet: carnitine. Office of Dietary Supplements website. Available at: http://ods.od.nih.gov/factsheets/Carnitine-...lthProfessional/. Accessed September 7, 2012.
Last reviewed September 2012 by EBSCO CAM Review Board
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.